Follitropin alfa biosimilar (JCR Pharmaceuticals/Aska)

促卵泡激素α生物类似药 (JCR Pharmaceuticals/Aska)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFollitropin alfa biosimilar (JCR Pharmaceuticals/Aska)
Drug Alias Name促卵泡激素α生物仿制药 (JCR Pharmaceuticals/Aska)Recombinant follicle-stimulating hormone (JCR Pharmaceuticals/Aska)Follitropin α biosimilar (JCR Pharmaceuticals/Aska)JR-041AKP-501
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJcr Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAska Pharmaceutical Co LtdJcr Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsInfertility
Inactive IndicationsN/A

Other Information

ATC CodeG03GA05
Related LinksN/A